MGP and hypercalcemia disease: During the arterial media calcification process, an imbalance of calcification inhibitors (ie, pyrophosphate [PPi], matrix Gla protein [MGP], and fetuin-A) and stimulators (ie, hyperphosphatemia, hypercalcemia, and uremic toxins) is observed.